Glucocorticoids and Central Nervous System Inflammation

References

• Adamson DC, Wildemann B, Sasaki M, Glass JD, McArthur JC, Christov VI, Dawson TM, Dawson VL (1996). Im-munologic NO synthase: elevation in severe AIDS de-mentia and induction by HIV-1 gp41. Science 274: 1917–1921.
   Google Scholar
• Aisen PS, Davis KL, Berg JD, Schafer K, Campbell K, Thomas RG, Weiner MF, Farlow MR, Sano M, Grundman M, Thal LJ (2000). A randomized controlled trial of pred-nisone in Alzheimer's disease. Alzheimer's Disease Co-operative Study. Neurology 54: 588–593.
   Google Scholar
• Akassoglou K, Probert L, Kontogeorgos G, Kollias G (1997). Astrocyte-specific but not neuron-specific transmem-brane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice. J Im-munol 158: 438–445.
   Google Scholar
• Akiyama H, Tooyama I, Kondo H, Ikeda K, Kimura H, McGeer EG, McGeer PL (1994). Early response of brain resident microglia to kainic acid-induced hippocampal lesions. Brain Res 635: 257–268.
   Google Scholar
• Alcorn JM, Fierer J, Chojkier M (1992). The acute-phase response protects mice from D-galactosamine sensitiza-tion to endotoxin and tumor necrosis factor-alpha. Hep-atology 15: 122–129.
   Google Scholar
• Andersson J (1996). Clinical and immunological consider-ations in Epstein-Barr virus-associated diseases. Scand J Infect Dis 100: 72–82.
   Google Scholar
• Asanuma M, Nishibayashi-Asanuma S, Miyazaki I, Kohno M, Ogawa N (2001). Neuroprotective effects of non-steroidal anti-inflammatory drugs by direct scavenging of nitric oxide radicals. J Neurochem 76: 1895–1904.
   PubMed Web of Science ®Google Scholar
• Badie B, Schartner JM, Paul J, Bartley BA, Vorpahl J, Preston JK (2000). Dexamethasone-induced abolition of the inflammatory response in an experimental glioma model: a flow cytometry study. J Neurosurg 93: 634–639.
   PubMedGoogle Scholar
• Bailey JM, Makheja AN, Pash J, Verma M (1988). Cor-ticosteroids suppress cyclooxygenase messenger RNA levels and prostanoid synthesis in cultured vascu-lar cells. Biochem Biophys Res Commun 157: 1159–1163.
   Google Scholar
• Banati RB, Gehrmann J, Schubert P, Kreutzberg GW (1993). Cytotoxicity of microglia. Glia 7: 111–118.
   PubMed Web of Science ®Google Scholar
• Barber AE, Coyle SM, Marano MA, Fischer E, Calvano SE, Fong Y, Moldawer LL, Lowry SF (1993). Glucocorticoid therapy alters hormonal and cytokine responses to en-dotoxin in man. J Immunol 150: 1999–2006.
   Google Scholar
• Barnes PJ, Adcock I (1993). Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci 14: 436–441.
   PubMed Web of Science ®Google Scholar
• Barone FC, Feuerstein GZ (1999). Inflammatory mediators and stroke: new opportunities for novel therapeutics. J Cereb Blood Flow Metab 19: 819–834.
   PubMed Web of Science ®Google Scholar
• Bauer ME, Vedhara K, Perks P, Wilcock GK, Lightman SL, Shanks N (2000). Chronic stress in caregivers of demen-tia patients is associated with reduced lymphocyte sen-sitivity to glucocorticoids. J Neuroimmunol 103: 84–92.
   Google Scholar
• Baumann H, Gauldie J (1995). The acute phase response. Immunol Today 15: 74–80.
   Google Scholar
• Beal MF (1992). Mechanisms of excitotoxicity in neuro-logic diseases. FASEB J 6: 3338–3344.
   PubMed Web of Science ®Google Scholar
• Beal MF (1995). Aging, energy, and oxidative stress in neu-rodegenerative diseases. Ann Neurol 38: 357–366.
   PubMed Web of Science ®Google Scholar
• Beamer NB, Coull BM, Clark WM, Briley DP, Wynn M, Sexton G (1998). Persistent inflammatory response in stroke survivors. Neurology 50: 1722–1728.
   PubMed Web of Science ®Google Scholar
• Becher B, Barker PA, Owens T, Antel JP (1998). CD95-CD95L: can the brain learn from the immune system? Trends Neurosci 21: 114–117.
   Google Scholar
• Becker KJ (1998). Inflammation and acute stroke. Curr Opin Neurol 11: 45–49.
   PubMed Web of Science ®Google Scholar
• Becker KJ (2001). Targeting the central nervous system inflammatory response in ischemic stroke. Curr Opin Neurol 14: 349–353.
   Google Scholar
• Belvisi MG, Brown TJ, Wicks S, Foster ML (2001). New glucocorticosteroids with an improved therapeutic ratio? Pulm Pharmacol Ther 14: 221–227.
   Google Scholar
• Ben-Hur T, Cialic R, Itzik A, Barak O, Yirmiya R, Weidenfeld J (2001). A novel permissive role for glu-cocorticoids in induction of febrile and behavioral signs of experimental herpes simplex virus encephalitis. Neu-rosci 108: 119–127.
   Google Scholar
• Bergsteindottir K, Brennan A, Jessen KR, Mirsky R (1992). In the presence of dexamethasone, gamma in-terferon induces rat oligodendrocytes to express major histocompatibility complex class II molecules. Proc Nati Acad Sci USA 89: 9054–9058.
   Google Scholar
• Berkenbosch F, van Oers J, del Rey A, Tilders F, Besedovsky H (1987). Corticotropin-releasing factor-producing neu-rons in the rat activated by interleukin-1. Science 238: 524–526.
   PubMed Web of Science ®Google Scholar
• Besedovsky H, del Rey A, Sorkin E, Dinarello CA (1986). Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 233: 652–654.
   PubMed Web of Science ®Google Scholar
• Bhargava A, Meijer OC, Dallman MF, Pearce D (2000). Plasma membrane calcium pump isoform 1 gene expres-sion is repressed by corticosterone and stress in rat hip-pocampus. J Neurosci 20: 3129–3138.
   Google Scholar
• Birnstiel S, List TJ, Beck SG (1995). Chronic corticosterone treatment maintains synaptic activity of CA1 hippocam-pal pyramidal cells: acute high corticosterone adminis-tration increases action potential number. Synapse 20: 117–124.
   PubMed Web of Science ®Google Scholar
• Bone RC, Fisher CJ Jr, Cle=er TP, Slotrnan GJ, Metz CA, Balk RA (1987). A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl j Med 317: 653–658.
   PubMed Web of Science ®Google Scholar
• Boumpas DT, Chrousos GP, Wilder RL, Cupps TR, Balow JE (1993). Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann Intern Med 119: 1198–1208.
   PubMed Web of Science ®Google Scholar
• Bracken MB, Shepard MJ, Collins WF, Holford TR, Young W, Baskin DS, Eisenberg HM, Flamm E, Leo-Summers L, Maroon J, et al (1990). A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. NEng/JMed 322: 1405–1411.
   Google Scholar
• Bracken MB, Shepard MJ, Holford TR, Leo-Summers L, Aldrich EF, Fazl M, Fehlings M, Herr DL, Hitchon PW, Marshall LF, Nockels RP, Pascale V, Perot PL Jr, Piepmeier J, Sonntag VK, Wagner F, Wilberger JE, Winn HR, Young W (1997). Administration of methylpred-nisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. JAMA 277: 1597–1604.
   Google Scholar
• Breitner JC (1996). The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease. Annu Rev Med 47: 401–411.
   PubMed Web of Science ®Google Scholar
• Bruccoleri A, Pennypacker KR, Harry GJ (1999). Effect of dexamethasone on elevated cytokine mRNA levels in chemical-induced hippocampal injury. J Neurosci Res 57: 916–926.
   Google Scholar
• Bruce AJ, Boling W, Kindy MS, Peschon J, Kraemer PJ, Carpenter MK, Holtsberg FW, Mattson MP (1996). Al-tered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF recep-tors. Nat Med 2: 788–794.
   PubMed Web of Science ®Google Scholar
• Brusaferri F, Candelise L (2000). Steroids for multiple scle-rosis and optic neuritis: a meta-analysis of randomized controlled clinical trials. J Neurol 247: 435–442.
   PubMed Web of Science ®Google Scholar
• Bucala R (1996). MIF rediscovered: cytokine, pituitary hor-mone, and glucocorticoid-induced regulator of the im-mune response. FASEB J10: 1607–1613.
   PubMed Web of Science ®Google Scholar
• Burchard K (2001). A review of the adrenal cortex and severe inflammation: quest of the "eucorticoid" state. J Trauma 51: 800–814.
   PubMed Web of Science ®Google Scholar
• Burton JL, Kehril ME Jr, Kapsil S, Horst RL (1995). Regu-lation of L-selectin and CD18 on bovine neutrophils by glucocorticoids: effects of cortisol and dexamethasone. J Leukoc Biol 57: 317–325.
   PubMed Web of Science ®Google Scholar
• Calandra T, Bemhagen J, Metz CN, Spiegel LA, Bacher M, Donnelly T, Cerami A, Bucala R (1995). MIF as a glucocorticoid-induced modulator of cytokine produc-tion. Nature 377: 68–71.
   PubMed Web of Science ®Google Scholar
• Camelo S, Lafage M, Lafon M (2000). Absence of the p55 Kd TNF-alpha receptor promotes survival in rabies virus acute encephalitis. J Neurovirol 6: 507–518.
   Google Scholar
• Campbell IL, Abraham CR, Masliah E, Kemper P, Inglis JD, Oldstone MB, Mucke L (1993). Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc Natl Acad Sci USA 90: 10061–10065.
   Google Scholar
• Calogero AE, Sternberg EM, Bagdy G, Smith C, Bemardini R, Aksentijevich S, Wilder RL, Gold PW, Chrousos GP (1992). Neurotransmitter-induced hypothalamic-pituitary-adrenal axis responsiveness is defective in in-flammatory disease-susceptible Lewis rats: in vivo and in vitro studies suggesting globally defective hypothala-mic secretion of corticotropin-releasing hormone. Neu-roendocrinology 55: 600–608.
   PubMedGoogle Scholar
• Cato AC, Wade E (1996). Molecular mechanisms of anti-inflammatory action of glucocorticoids. BioEssays 18: 371–378.
   PubMed Web of Science ®Google Scholar
• Cavallo MG, Baroni Mg, Toto A, Gearing AJ, Forsey T, Andreani D, Thorpe R, Pozzilli P (1992). Viral infections induces cytokine release by beta islet cells. Immunology 75: 664–668.
   PubMed Web of Science ®Google Scholar
• Chapman GA, Moores K, Harrison D, Campbell CA, Stewart BR, Strijbos PJ (2000). Fractalkine cleavage from neu-ronal membranes represents an acute event in the in-flammatory response to excitotoxic brain damage. J Neu-rosci 20: RC87.
   Google Scholar
• Cheng B, Christakos S, Mattson MP (1994). Tumor necrosis factors protect neurons against metabolic-excitotoxic in-sults and promote maintenance of calcium homeostasis. Neuron 12: 139–153.
   PubMed Web of Science ®Google Scholar
• Chrousos GP (1995). The hypothalamic-pituitary-adrenal axis and immune mediated inflammation. N Engl j Med 332: 1351–1362.
   PubMed Web of Science ®Google Scholar
• Colton C, Wilt S, Gilbert D, Chernyshev O, Snell J, Dubois-Dalcq M (1996). Species differences in the gener-ation of reactive oxygen species by microglia. Mol Chem Neuropathol 28: 15–20.
   Google Scholar
• Cox G, Austin RC (1997). Dexamethasone-induced sup-pression of apoptosis in human neutrophils requires continuous stimulation of new protein synthesis. J Leukoc Biol 61: 224–230.
   PubMed Web of Science ®Google Scholar
• Coyle PK (1999). Glucocorticoids in central nervous system bacterial infection. Arch Neurol 56: 796–801.
   PubMed Web of Science ®Google Scholar
• Craig CR, Stitzel RE (1994). Modern pharmacology, 4th ed. Boston: Little, Brown, p 737.
   Google Scholar
• Cronin L, Cook DJ, Carlet J, Heyland DK, King D, Lansang MA, Fisher CJ Jr (1998). Corticosteroid treatment for sep-sis: a critical appraisal and meta-analysis of the litera-ture. Grit Care Med 23: 1430–1439.
   Google Scholar
• Cronstein BN, Kimmel SC, Levin RI, Martiniuk F, Weissmann G (1992). A mechanism for the antiin-flammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc Natl Acad Sci USA 89: 9991–9995.
   PubMed Web of Science ®Google Scholar
• Dalakas MC (1995). Basic aspects of neuroi=unology as they relate to immunotherapeutic targets: present and future prospects. Ann Neurol 37 (Suppl 1): S2–S13.
   Google Scholar
• David JR (1966). Delayed hypersensitivity in vitro: its me-diation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Nati Acad Sci USA 56: 72–77.
   PubMed Web of Science ®Google Scholar
• Davis JM, Albert JD, Tracy KJ, Calvano SE, Lowry SF, Shires GT, Yurt RW (1991). Increased neutrophil mobi-lization and decreased chemotaxis during cortisol and epinephrine infusions. J Trauma 31: 725–731; discus-sion 731–732.
   Google Scholar
• de Bock F, Domand J, Rondouin G (1996). Release of TNF al-pha in the rat hippocampus following epileptic seizures and excitotoxic neuronal damage. Neuroreport 7: 1125–1129.
   Google Scholar
• De Bosscher K, Vanden Berghe W, Haegeman G (2000). Mechanisms of antiinfla=atory action and of i=uno-suppression by glucocorticoids: negative interference of activated glucocorticoid receptor with transcription fac-tors. J Neuroimmunol 109: 16–22.
   PubMed Web of Science ®Google Scholar
• De Kloet ER, Vreugdenhil E, Oitzl MS, Joels M (1998). Brain corticosteroid receptor balance in health and disease. Endocr Rev 19: 269–301.
   Google Scholar
• DeGraba TJ (1998). The role of inflammation after acute stroke: utility of pursuing anti-adhesion molecule ther-apy. Neurology 51 (Suppl 3): S62–S68.
   Google Scholar
• DeGraba TJ, Pettigrew LC (2000). Why do neuroprotective drugs work in animals but not humans? Neurol Clin 18: 475–493.
   Google Scholar
• De Keyser J, Sulter G, Luiten PG (1999). Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing? Trends Neurosci 22: 535–540.
   Google Scholar
• DeRijk R, Michelson D, Karp B, et al (1997). Exercise and circadian rhythm-induced variations in plasma cortisol differentially regulate interleukin-1 beta (IL-1 beta), IL-6, and tumor necrosis factor-alpha (TNF alpha) production in humans: high sensitivity of TNF alpha and resistance of IL-6. J Clin Endocrinol Metab 82: 2182–2191.
   PubMed Web of Science ®Google Scholar
• del Zoppo GJ, Becker KJ, Hallenbeck JM (2001). Inflamma-tion after stroke: is it harmful? Arch Neurol 58: 669–672.
   Google Scholar
• Dermietzel R (1975). Junctions in the central nervous sys-tem of the cat. IV. Interendothelial junctions of cerebral blood vessels from selected areas of the brain. Cell Tissue Res 164: 45–62.
   Google Scholar
• Dhabhar FS, Miller AH, McEwen BS, Spencer RL (1996). Stress-induced changes in blood leukocyte distribution. Role of adrenal steroid hormones. J Immuno1157: 1638–1644.
   Google Scholar
• Dhabhar FS, McEwen BS (1996). Stress-induced enhance-ment of antigen-specific cell-mediated immunity. J Im-munol 156: 2608–2615.
   PubMed Web of Science ®Google Scholar
• Dhabhar FS, McEwen BS (1997). Acute stress enhances while chronic stress suppresses cell-mediated immunity in vivo: a potential role for leukocyte trafficking. Brain Behav Immun 11: 286–306.
   PubMed Web of Science ®Google Scholar
• Dinkel K, Sapolsky RM (2003). Novel glucocorticoid effects on acute inflammation in the central nervous system. J Neurochem In press.
   Google Scholar
• Dirnagl U, Iadecola C, Moskowitz MA (1999). Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22: 391–397.
   PubMed Web of Science ®Google Scholar
• Dodd DA, Giddings TH Jr, Kirkegaard K (2001). Poliovirus 3A protein limits interleukin-6 (IL-6), IL-8, and beta interferon secretion during viral infection. J Virol 75: 8158–8165.
   PubMed Web of Science ®Google Scholar
• Domachowske JB, Bonville CA, Ali-Ahmad D, Dyer KD, Easton AJ, Rosenberg HF (2001). Glucocorticoid admin-istration accelerates mortality of pneumovirus-infected mice. /Infect Dis 184: 1518–1523.
   PubMed Web of Science ®Google Scholar
• Donnelly SC, Bucala R (1997). Macrophage migration in-hibitory factor: a regulator of glucocorticoid activity with a critical role in inflammatory disease. Mol Med Today Nov: 502–507.
   Google Scholar
• Elenkov IJ, Webster EL, Torpy DJ, Chrousos GP (1999). Stress, corticotropin-releasing hormone, glucocorti-coids, and the immune/inflammatory response: acute and chronic effects. Ann N Y Acad Sci 876: 1–11; dis-cussion 11–13.
   Google Scholar
• Emilie D, Crevon MC, Auffredou MT, Galanaud P (1988). Glucocorticosteroid-dependent synergy between inter-leukin 1 and interleukin 6 for human B lymphocyte dif-ferentiation. Eur J Immunol 18: 2043–2047.
   Google Scholar
• Ferguson TA, Griffith TS (1997). A vision of cell death: in-sights into immune privilege. Immunol Rev 156: 167–184.
   Google Scholar
• Fernandez-Ruiz E, Rebollo A, Nieto MA, Sanz E, Somoza C, Ramirez F, Lopez-Rivas A, Silva A (1989). IL-2 protects T cell hybrids from the cytolytic effect of glucocorticoids. Synergistic effect of IL-2 and dexamethasone in the in-duction of high-affinity IL-2 receptors. J Immunol 143: 4146–4151.
   Google Scholar
• Feuerstein GZ, Wang X (2001). Inflammation and stroke: benefits without harm? Arch Neurol 58: 672–674.
   Google Scholar
• Feuerstein GZ, Wang X, Barone FC (1998). In: Cerebrovas-cular disease: path ophysiology, diagnosis and manage-ment. Ginsberg M, Bogousslavsky J (eds.). Blackwell Sci-ence: Oxford, UK, pp 507–531.
   Google Scholar
• Flippini G, Brusaferri F, Sibley WA, Citterio A, Ciucci G, Midgard R, Candelise L (2000). Corticosteroids or ACTH for acute exacerbations in multiple sclerosis. Cochrane Database Syst Rev 4.
   Google Scholar
• Fishman RA (1982). Steroids in the treatment of brain edema. N Engl j Med 306: 359–360.
   Google Scholar
• Foss HD, Herbst H, Hummel M, Araujo I, Latza U, Rancso C, Dallenbach F, Stein H (1994). Patterns of cytokine gene expression in infectious mononucleosis. Blood 84: 707–712.
   Google Scholar
• Fox RJ, Levin MC, Jacobson S (1996). Tumor necrosis fac-tor alpha expression in the spinal cord of human T-cell lymphotrophic virus type I associated myelopathy/ tropical spastic paraparesis patients. I Neurovirol 2: 297–298.
   Google Scholar
• Galicich J, French L, Melly J (1961). Use of dexamethasone in treatment of cerebral edema associated with brain tu-mor. J Lancet 81: 46.
   PubMedGoogle Scholar
• Gary DS, Bruce-Keller AJ, Kindy MS, Mattson MP (1998). Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor. J Cereb Blood Flow Metab 18: 1283–1287.
   PubMed Web of Science ®Google Scholar
• Getting SJ, Flower RJ, Perretti M (1997). Inhibition of neu-trophil and monocyte recruitment by endogenous and exogenous lipocortin 1. Br J Pharmacol 120: 1075–1082.
   Google Scholar
• Ghosh D (1992). Glucocorticoid receptor binding site in the HIV long terminal repeat. J Virol 66: 586–590.
   Google Scholar
• Glaser R, Kiecolt-Glaser JK (1998). Stress-associated im-mune modulation: relevance to viral infections and chronic fatigue syndrome (review). Am J Med 105: 35S–42S.
   Google Scholar
• Gosselin J, Flamand L, D'Addario M, Hiscott J, Menezes J (1992). Infection of peripheral blood mononuclear cells by herpes simplex and Epstien-Barr viruses. Differential induction of interleukin 6 and tumor necrosis factor-alpha. J Clin Invest 89: 1849–1856.
   Google Scholar
• Gould E, McEwen B, Tanapat P, Galea L, Fuchs E (1997). Neurogenesis in the dentate gyms of the adult tree shrew is regulated by psychosocial stress and NMDA receptor activation. J Neurosci 18: 2492.
   Google Scholar
• Gould E, Tanapat P, McEwen B, Flugge G, Fuchs E (1998). Proliferation of granule cell precursors in the dentate gyms of adult monkeys is diminished by stress. Proc Natl Acad Sci USA 95: 3168.
   PubMed Web of Science ®Google Scholar
• Goulding NJ, Euzger HS, Butt SK, Perretti M (1998). Novel pathways for glucocorticoid effects on neutrophils in chronic inflammation. Inflamm Res 47\(Suppl 3): S158–S165.
   Google Scholar
• Griffin DE, Wesselingh SL, McArthur JC (1994). Elevated central nervous system prostaglandins in human im-munodeficiency virus-associated dementia. Ann Neurol 35: 592–597.
   PubMed Web of Science ®Google Scholar
• Hall ED, Braughler JM (1982). Glucocorticoid mechanisms in acute spinal cord injury: a review and therapeutic rationale. Surg Neurol 18: 320–327.
   PubMedGoogle Scholar
• Hardwicke MA, Schaffer PA (1997). Differential effects of nerve growth factor and dexamethasone on herpes sim-plex virus type 1 oriL and oriS dependent DNA replica-tion in PC12 cell. J Virol 71: 3580–3587.
   Google Scholar
• Heim A, Zeuke S, Weiss S, Ruschewski W, Grumbach IM (2000). Transient induction of cytokine production in human myocardial fibroblasts by coxsackievirus B3. Circ Res 86: 753–759.
   Google Scholar
• Hench P, Kendall EC, Slocumb CH, Polley HF (1949). The effects of a hormone of the adrenal cortex and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. Proc Mayo Clin 24: 181–197.
   PubMed Web of Science ®Google Scholar
• Hetier E, Ayala J, Bousseau A, Prochiantz A (1991). Mod-ulation of interleukin-1 and tumor necrosis factor ex-pression by beta-adrenergic agonists in mouse ameboid microglial cells. Exp Brain Res 86: 407–413.
   PubMed Web of Science ®Google Scholar
• Hildeman D, Muller D (2000). Immunopathologic weight loss in intracranial LCMV infection initiated by the anorexigenic effects of IL-1 beta. Viral Immuno113: 273–285.
   Google Scholar
• Hughes RA, van Der Meche FG (2000). Corticosteroids for treating Guillain-Barre syndrome. Cochrane Database Syst Rev 3.
   Google Scholar
• Iadecola C (1997). Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci 20: 132–139.
   PubMed Web of Science ®Google Scholar
• Iadecola C, Alexander M (2001). Cerebral ischemia and inflammation. Curr Opin Neurol 14: 89–94.
   PubMed Web of Science ®Google Scholar
• Ilyin SE, Plata-Salaman CR (1997). HIV-1 envelope glyco-protein 120 regulates brain IL-1 beta system and TNF-alpha mRNAs in vivo. Brain Res Bull 44: 67–73.
   PubMed Web of Science ®Google Scholar
• Inagi R, Guntapong R, Nakao M, Ishino Y, Kawanishi K, Isegawa Y, Yamanishi K (1996). Human herpesvirus 6 induces IL-8 gene expression in human hepatoma cell line, Hep G2. J Med Virol 49: 34–40.
   Google Scholar
• Jacobson L, Sapolsky R (1991). The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocr Rev 12: 118–134.
   PubMed Web of Science ®Google Scholar
• Joblonowska E, Lisiewicz J, Kuydowicz J, Pojda Z (1999). Levels of interleukin-6 in cerebrospinal fluid of patients with meningitis. Neurol Neurochir Polska 32: 161–165.
   Google Scholar
• Joels M (2001). Corticosteroid actions in the hippocampus. J Neumendocrino113: 657–669.
   Google Scholar
• Joels M, de Kloet E (1989). Effects of glucocorticoids and norepinephrine on the excitability in the hippocampus. Science 245: 1502–1505.
   PubMedGoogle Scholar
• Juttner S, Bernhagen J, Metz CN, Rollinghoff M, Bucala R, Gessner A (1998). Migration inhibitory factor induces killing of Leishmania major by macrophages: depen-dence on reactive nitrogen intermediates and endoge-nous TNF-alpha. J Immunol 161: 2383–2390.
   PubMedGoogle Scholar
• Kellendonk C, Tronche F, Reichardt HM, Schutz G (1999). Mutagenesis of the glucocorticoid receptor in mice. J Steroid Biochem Mol Biol 69: 253–259.
   PubMed Web of Science ®Google Scholar
• Kern JA, Lamb RJ, Reed JC, Daniele RP, Nowell PC (1988). Dexamethas one inhibition of interleukin 1 beta produc-tion by human monocytes. Posttranscriptional mecha-nisms. J Clin Invest 81: 237–244.
   Google Scholar
• Kerr D, Campbell L, Hao S, Landfield P (1989). Cortico-steroid modulation of hippocampal potentials: in-creased effect with aging. Science 245: 1505–1509.
   PubMedGoogle Scholar
• Kerschensteiner M, Gallmeier E, Behrens L, Leal VV, Misgeld T, Klinkert VVE, Kolbeck R, Hoppe E, Oropeza-Wekerle RL, Bartke I, Stadelmann C, Lassmann H, Wekerle H, Hohlfeld R (1999). Activated human T cells, B cells, and monocytes produce brain-derived neu-rotrophic factor in vitro and in inflammatory brain le-sions: a neuroprotective role of infla=ation? jExp Med 189: 865–870.
   Google Scholar
• Kino T, Chrousos GP (2001). Glucocorticoid and mineralo-corticoid resistance/hypersensitivity syndromes. J En-docrino1169: 437–445.
   Google Scholar
• Kiwerski JE (1993). Application of dexamethasone in the treatment of acute spinal cord injury. Injury 24: 457–460.
   PubMed Web of Science ®Google Scholar
• Koedel U, Kohleisen B, Sporer B, Lahrtz F, Ovod V, Fontana A, Erfle V, Pfister HW (1999). HIV type 1 Nef protein is a viral factor for leukocyte recruitment into the central nervous system. J Immunol 163: 1237–1245.
   Google Scholar
• Koide T, Wieloch TW, Siesjo BK (1986). Chronic dex-amethasone pretreatment aggravates ischemic neuronal necrosis. J Cereb Blood Flow Metab 6: 395–404.
   PubMedGoogle Scholar
• Kreutzberg GW (1996). Microglia: a sensor for patho-logical events in the CNS. Trends Neurosci 19: 312–318.
   PubMed Web of Science ®Google Scholar
• Kupfer SR, Summers WC (1990). Identification of a glucocorticoid-responsive element in Epstein-Barr virus. J Virol 64: 1984–1990.
   PubMedGoogle Scholar
• Landfield PW, Baskin RK, Pitler TA (1981). Brain aging cor-relates: retardation by hormonal-pharmacological treat-ments. Science 214: 581–584.
   PubMed Web of Science ®Google Scholar
• Lee JM, Zipfel GJ, Choi DW (1999). The changing landscape of ischaemic brain injury mechanisms. Nature 399(6738 Suppl): A7–A14.
   Google Scholar
• Leech M, Metz C, Hall P, Hutchinson P, Gianis K, Smith M, Weedon H, Holdsworth SR, Bucala R, Morand EF (1999). Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinfla=atory function and reg-ulation by glucocorticoids. Arthritis Rheum 42: 1601–1608.
   PubMed Web of Science ®Google Scholar
• Lefering R, Neugebauer EA (1995). Steroid controversy in sepsis and septic shock: a meta-analysis. Grit Care Med 23: 1294–1303.
   PubMed Web of Science ®Google Scholar
• Leopardi R, Vainionpaa R, Hurme M, Siljander P, Salmi AA (1992). Measles virus infection enhances IL-1 beta but reduces tumor necrosis factor-alpha expression in human moncytes. J Immunol 149: 2397–2401.
   Google Scholar
• Liao J, Keiser JA, Scales VVE, Kunkel SL, Kluger MJ (1995). Role of epinephrine in TNF and IL-6 production from isolated perfused rat liver. Am J Physiol 268(4 Pt 2): R896–R901.
   Google Scholar
• Liles WC, Dale DC, Klebanoff SJ (1995). Glucocorticoids in-hibit apoptosis of human neutrophils. Blood 86: 3181–3188.
   PubMed Web of Science ®Google Scholar
• Lilly MP, Gann DS (1992). The hypothalamic-pituitary-adrenal-immune axis. Arch Surg 127: 1463–1474.
   PubMedGoogle Scholar
• Limoges J, Persidsky Y, Bock P, Gendelman HE (1997). Dexamethasone therapy worsens the neuropathology of human immunodeficiency virus type 1 encephalitis in SCID mice. J Infect Dis 175: 1368–1381.
   Google Scholar
• Lipton SA, Rosenberg PA (1994). Excitatory amino acids as a final common pathway for neurologic disorders. N Engl j Med 330: 613–622.
   PubMed Web of Science ®Google Scholar
• Magarinos AM, Deslandes A, McEwen BS (1999). Effects of antidepressants and benzodiazepine treatments on the dendritic structure of CA3 pyramidal neurons after chronic stress. Eur j Pharmacol 371: 113–122.
   PubMed Web of Science ®Google Scholar
• Marquette C, van Dam AM, Ceccaldi PE, Weber P, Haour F, Tsiang H (1996). Induction of i=unoreactive interleukin-1 beta and tumor necrosis factor alpha in the brains of rabies virus infected rats. J Neuroimmunol 68: 45–51.
   Google Scholar
• Marx J (1995). How the glucocorticoids suppress immunity. Science 270: 232–233.
   PubMed Web of Science ®Google Scholar
• McEwen BS (1998). Protective and damaging effects of stress mediators. N Engl j Med 238: 171–179.
   Google Scholar
• McEwen BS (2000). The neurobiology of stress: from serendipity to clinical relevance. Brain Res 886: 172–189.
   PubMed Web of Science ®Google Scholar
• McEwen BS, Albeck D, Cameron H, Chao HM, Gould E, Hastings N, Kuroda Y, Luine V, Magarinos AM, McKittrick CR, et al (1995). Stress and the brain: a para-doxical role for adrenal steroids. Vitam Horm 51: 371–402.
   PubMed Web of Science ®Google Scholar
• McEwen BS, De Kloet ER, Rostene W (1986). Adrenal steroid receptors and actions in the nervous system. Physiol Rev 66: 1121–1188.
   PubMed Web of Science ®Google Scholar
• McEwen BS, Magarinos AM (1997). Stress effects on mor-phology and function of the hippocampus. Ann N Y Acad Sci 821: 271–284.
   PubMed Web of Science ®Google Scholar
• McGaugh JL (2000). Memory-a century of consolidation. Science 287: 248–251.
   PubMed Web of Science ®Google Scholar
• McGeer EG, McGeer PL (1994). Neurodegeneration and the immune system. In: Neurodegenerative disorders. Calne DB (ed). WB Saunders: Philadelphia, PA, pp 277–300.
   Google Scholar
• McGeer EG, McGeer PL (1999). Brain inflammation in Alzheimer disease and the therapeutic implications. Curr Pharm Des 5: 821–836.
   PubMed Web of Science ®Google Scholar
• McGeer PL, McGeer EG (1995). The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Brain Res Rev 21: 195–218.
   PubMed Web of Science ®Google Scholar
• Meaney MJ (1988). The sexual differentiation of social play. Trends Neurosci 11: 54–58.
   PubMed Web of Science ®Google Scholar
• Miller G, Davis J (1991). Post-ischemic surge in corticos-teroids aggravates ischemic damage to gerbil CA1 pyra-midal cells. Soc Neurosci Abst 17: 302.4.
   Google Scholar
• Millikan CH, McDowell F, Easton JD (1987). Progressing stroke. In: Stroke. Millikan CH, McDowell F, Easton JD (eds). Lea & Febiger, Philadelphia, PA, pp 117–130.
   Google Scholar
• Mori N, Prager D (1996). Transactivation of the interleukin-1 alpha promoter by the human T-cell leukemia virus type I and type II Tax proteins. Blood 87: 3410–3417.
   PubMed Web of Science ®Google Scholar
• Mukaida N, Zachariae CC, Gusella GL, Matsushima K (1991). Dexamethasone inhibits the induction of mono-cyte chemotactic-activating factor production by IL-1 or tumor necrosis factor. J Immunol 146: 1212–1215.
   PubMedGoogle Scholar
• Munck A, Guyre PM, Holbrook NJ (1984). Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev 5: 25–44.
   PubMed Web of Science ®Google Scholar
• Munck A, Naray-Fejes-Toth A (1994). Glucocorticoids and stress: permissive and suppressive actions. Ann N Y Acad Sci 746: 115–130.
   PubMed Web of Science ®Google Scholar
• Nelson DH (1995). Historical overview of the adrenal cortex. In: Endocrinology, vol 3. Degroot L (ed). WB Saunders: Philadelphia, PA, p 257.
   Google Scholar
• Nesathurai S (1998). Steroids and spinal cord injury: revis-iting the NASCIS 2 and NASCIS 3 trials. J Trauma 45: 1088–1093.
   PubMed Web of Science ®Google Scholar
• Neumann H (2001). Control of glial immune function by neurons. Glia 36: 191–199.
   PubMed Web of Science ®Google Scholar
• Newton CJ, Bilko D, Pappa S, Atkin SL (2001). Dexametha-sone blocks antioestrogen- and oxidant-induced death of pituitary tumour cells. J Endocrino/ 169: 249–261.
   Google Scholar
• Neznanov N, Kondratova A, Chumakov KM, Angres B, Zhumbayeva B, Agol VI, Gudkov AV (2001). Poliovirus protein 3A inhibits tumor necrosis factor (TNF) induced apoptosis by eliminating the TNF receptor from the cell surface. J Virol 75: 10409–10420.
   PubMed Web of Science ®Google Scholar
• Nguyen KB, Biron CA (1999). Synergism for cytokine-mediated disease during concurrent endotoxin and viral challenges: roles for NK and T and IFN-gamma produc-tion. J Immuno1162: 5238–5246.
   Google Scholar
• Nishikawa M, Matsubara T, Yoshitomi T, Ichiyama T, Hayashi T, Furukawa S (2000). Abnormalities of brain perfusion in echovirus type 30 meningitis. J Neuro Sci 179(S1-S2): 122–126.
   Google Scholar
• Nishio Y, Isshiki H, Kishimoto T, Akira S (1993). A nu-clear factor for interleukin-6 expression (NF-1L6) and the glucocorticoid receptor synergistically activate tran-scription of the rat alpha 1-acid glycoprotein gene via di-rect protein-protein interaction. Mol Cell Biol 13: 1854–1862.
   PubMed Web of Science ®Google Scholar
• Nogawa S, Zhang F, Ross ME, Iadecola C (1997). Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage. J Neurosci 17: 2746–2755.
   PubMed Web of Science ®Google Scholar
• Noisakran S, Halford WP, Veress L, Carr DL (1998). Role of the hypothalamic pituitary adrenal axis and IL-6 in stress-induced reactivation of latent herpes simplex virus type 1. J Immuno1160: 5441–5447.
   Google Scholar
• Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG (2000). Multiple sclerosis. N Engl j Med 343: 938–952.
   PubMed Web of Science ®Google Scholar
• Nuovo GJ, Alfieri ML (1996). AIDS dementia is associated with massive, activated HIV-1 infection and concomi-tant expression of several cytokines. Mol Med 2: 358–366.
   PubMed Web of Science ®Google Scholar
• Olney JW (1978). Neurotoxicity of excitatory amino acids. In: Kainic acid as a tool in neurobiology. McGeer EG, Olney JW, McGeer PL (eds). Raven Press: New York; pp 95–121.
   Google Scholar
• O'Neill LA, Kaltschmidt C (1997). NF-kappa B: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci 20: 252–258.
   PubMed Web of Science ®Google Scholar
• Ottaviani E, Franceschi C (1996). The neuroimmunology of stress from invertebrates to man. Prog Neurobiol 48: 421–440.
   PubMed Web of Science ®Google Scholar
• Pascuzzi RM, Coslett HB, Johns TR (1984). Long-term cor-ticosteroid treatment of myasthenia gravis: report of 116 patients. Ann Neurol 15: 291–298.
   PubMed Web of Science ®Google Scholar
• Pearce BD, Biron CA, Miller AH (2001). Neuroendocrine-immune interactions during viral infections (review). Adv Virus Res 56: 469–513.
   Google Scholar
• Perretti M, Flower RJ (1994). Cytokines, glucocorticoids and lipocortins in the control of neutrophil migration. Pharmacol Res 30: 53–59.
   Google Scholar
• Perry VH, Gordon S (1991). Macrophages and the nervous system. Int Rev Cytol 125: 203–244.
   PubMed Web of Science ®Google Scholar
• Peterson PK, Gekker G, Hu S, Chao CC (1997). Microglia: a "double-edged sword." In: In defense of the brain. Peterson PK, Remington JS (eds). Blackwell Science: Oxford, UK, pp 31–55.
   Google Scholar
• Pietzko D, Zohlnhofer D, Graeve L, Fleischer D, Stoyan T, Schooltink H, Rose-John S, Heinrich PC (1993). The hepatic interleukin-6 receptor. Studies on its struc-ture and regulation by phorbol 12-myristate 13-acetate-dexamethasone. J Biol Chem 268: 4250–4258.
   Google Scholar
• Ransohoff RM, Tani M (1998). Do chemokines mediate leukocyte recruitment in post-traumatic CNS inflamma-tion? Trends Neurosci 21: 154–159.
   Google Scholar
• Rapalino O, Lazarov-Spiegler O, Agranov E, Velan GJ, Yoles E, Fraidakis M, Solomon A, Gepstein R, Katz A, Belkin M, Hadani M, Schwartz M(1998). Implantation of stimu-lated homologous macrophages results in partial recov-ery of paraplegic rats. Nat Med 4: 814–821.
   Google Scholar
• Risau W, Wolburg H (1990). Development of the blood-brain barrier. Trends Neurosci 13: 174–178.
   PubMed Web of Science ®Google Scholar
• Rothwell NJ, Luheshi G, Toulmond S (1996). Cytokines and their receptors in the central nervous system: physiol-ogy, pharmacology, and pathology. Pharmacol Ther 69: 85–95.
   PubMed Web of Science ®Google Scholar
• Ruscher K, Isaev N, Trendelenburg G, Weih M, Iurato L, Meisel A, Dirnagl U (1998). Induction of hypoxia inducible factor 1 by oxygen glucose deprivation is attenuated by hypoxic preconditioning in rat cultured neurons. Neurosci Lett 254: 117–120.
   Google Scholar
• Ruzek MC, Miller AH, Opal SM, Pearce BD, Biron CA (1997). Characterization of early cytokine responses and an interleukin (IL)-6-dependent pathway of en- dogenous glucocorticoid induction during murine cy-tomegalovirus infection. J Exp Med 185: 1185–1192.
   PubMed Web of Science ®Google Scholar
• Ruzek MC, Pearce BD, Miller AH, Biron CA (1999). Endoge-nous glucocorticoids protect against cytokine-mediated lethality during viral infection. J Immunol 162: 3527–3533.
   Google Scholar
• Sanderson KL, Raghupathi R, Saatman KE, Martin D, Miller G, McIntosh TK (1999). Interleukin-1 receptor antago-nist attenuates regional neuronal cell death and cogni-tive dysfunction after experimental brain injury. J Cereb Blood-Flow Metab 19: 1118–1125.
   PubMed Web of Science ®Google Scholar
• Sapolsky RM (1985). A mechanism for glucocorticoid tox-icity in the hippocampus: increased neuronal vulnera-bility to necrotic insults. J Neurosci 5: 1228–1232.
   PubMed Web of Science ®Google Scholar
• Sapolsky RM (1992). Stress, the aging brain and the mech-anisms of neuron death, vol 1. MIT Press: Cambridge, MA, p 423.
   Google Scholar
• Sapolsky RM (1994). The physiological relevance of gluco-corticoid endangerment of the hippocampus. Ann N Y Acad Sci 746: 294–304; discussion 304–307.
   Google Scholar
• Sapolsky RM (1996). Why stress is bad for your brain. Science 273: 749–750.
   PubMed Web of Science ®Google Scholar
• Sapolsky RM, Krey LC, McEwen BS (1985). Prolonged glucocorticoid exposure reduces hippocampal neuron number: implications for aging. J Neurosci 5: 1222–1227.
   PubMed Web of Science ®Google Scholar
• Sapolsky RM, Pulsinelli WA (1985). Glucocorticoids po-tentiate ischemic injury to neurons: therapeutic impli-cations. Science 229: 1397–1400.
   PubMed Web of Science ®Google Scholar
• Sapolsky RM, Rivier C, Yamamoto G, Plotsky P, Vale W (1987). Interleukin-1 stimulates the secretion of hy-pothalamic corticotropin-releasing factor. Science 238: 522–524.
   PubMed Web of Science ®Google Scholar
• Sapolsky RM, Romero LM, Munck A (2000). How do glu-cocorticoids influence stress responses? Integrating per-missive, suppressive, stimulatory, and preparative ac-tions. Endocr Rev 21: 55–89.
   PubMed Web of Science ®Google Scholar
• Sauder C, Wolfer DP, Lipp HP, Staeheli P, Hausmann J (2001). Learning deficits in mice with persisent Boma disease virus infection of the CNS associated with ele-vated chemokine expression. Behav Brain Res 120: 189–201.
   Google Scholar
• Schneider-Schaulies J, Schneider-Schaulies S, Ter Meulen V (1993). Differential induction of cytokines by primary and persistent measles virus infection in human glial cells. Virology 195: 219–228.
   Google Scholar
• Schooltink H, Schmitz-Van de Leur H, Heinrich PC, Rose-John S (1992). Up-regulation of the interleukin-6-signal transducing protein (gp130) by interleukin-6 and dexa-methasone in HepG2 cells. FEBS Lett 297: 263–265.
   Google Scholar
• Schwartz M, Moalem G (2001). Beneficial immune activity after CNS injury: prospects for vaccination. J Neuroim-muno1113: 185–192.
   Google Scholar
• Segatore M (1999). Corticosteroids and traumatic brain in-jury: status at the end of the decade of the brain. J Neu-rosci Nurs 31: 239–250.
   Google Scholar
• Selye H (1936). A syndrome produced by diverse nocous agents. Nature 138: 32.
   Web of Science ®Google Scholar
• Selye H (1978). The stress of life. McGraw-Hill: New York.
   Google Scholar
• Stein-Behrens BA, Elliott EM, Miller CA, Schilling JW, Newcombe R, Sapolsky RM (1992). Glucocorticoids exacerbate kainic acid-induced extracellular accumula-tion of excitatory amino acids in the rat hippocampus. J Neurochem 58: 1730–1735.
   Google Scholar
• Sternberg EM, Hill JM, Chrousos GP, Kamilaris T, Listwak SJ, Gold PW, Wilder RL (1989). Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activa-tion is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc Nati Acad Sci USA 86: 2374–2378.
   PubMed Web of Science ®Google Scholar
• Stoll G, Jander S, Schroeter M (1998). Inflammation and glial responses in ischemic brain lesions. Prog Neurobiol 56: 149–171.
   Google Scholar
• Straub RH, Miller LE, Scholmerich J, Zietz B (2000). Cy-tokines and hormones as possible links between en-docrinosenescence and immunosenescence. J Neuroim-munol 109: 10–15.
   PubMed Web of Science ®Google Scholar
• Takikita S, Takano T, Narita T, Takikita M, Ohno M, Shimada M (2001). Neuronal apoptosis mediated by IL-1 beta expression in viral encephalitis caused by a neu-roadapted strain of the mumps virus (Kilham strain) in hamsters. Exp Neurol 172: 47–59.
   Google Scholar
• Tanaka J, Ogura T, Kamiya S, Sato H, Yoshie T, Ogura H, Hatano M (1984). Enhanced replication of human cy-tomegalovirus in human fibroblasts treated with dexam-ethasone. J Gen Virol 65: 1759–1767.
   Google Scholar
• Thompson KA, Blessing WW, Wesselingh SL (2000). Her-pes simplex replication and dissemination is not in-creased by corticosteroid treatment in a rat model of focal herpes encephalitis. J NeuroVirol 6: 25–32.
   Web of Science ®Google Scholar
• Tominaga T, Katagi H, Ohnishi ST (1988). Is Ca2±-activated potassium efflux involved in the formation of ischemic brain edema? Brain Res 460: 376–378.
   Google Scholar
• Trainer PJ, Faria M, Newell-Price J, et al (1995). A compar-ison of the effects of human and ovine corticotrophin-releasing hormone on the pituitary-adrenal axis. J UM Endocrinol Metab 80: 412–417.
   PubMed Web of Science ®Google Scholar
• Tyrrell JB, Aron DC, Forsham PH (1994). Glucocorti-coids and adrenal androgens. In: Basic and clinical en-docrinology. Greenspan FS, Baxter JD (eds). Appleton and Lange: Norwalk, CT, p 307.
   Google Scholar
• Uz T, Pesold C, Longone P, Manev H (1998). Aging-associated up-regulation of neuronal 5-lipoxygenase ex-pression: putative role in neuronal vulnerability. FASEB j 12: 439–449.
   PubMed Web of Science ®Google Scholar
• Uz T, Dwivedi Y, Savani PD, Impagnatiello F, Pandey G, Manev H (1999). Glucocorticoids stimulate inflam-matory 5-lipoxygenase gene expression and protein translocation in the brain. J Neurochem 73: 693–699.
   PubMedGoogle Scholar
• van der Velden VH (1998). Glucocorticoids: mechanisms of action and anti-inflammatory potential in asthma. Medi-ators Inflamm 7: 229–237.
   PubMed Web of Science ®Google Scholar
• Vecht CJ (1998). Clinical management of brain metastasis. J Neurol 245: 127–131.
   PubMed Web of Science ®Google Scholar
• Vedhara K, Cox NK, Wilcock GK, Perks P, Hunt M, Anderson S, Lightrnan SL, Shanks NM (1999). Chronic stress in elderly carers of dementia patients and an-tibody response to influenza vaccination. Lancet 353: 627–631.
   Google Scholar
• Vila N, Castillo J, Davalos A, Chamorro A (2000). Proin-flammatory cytokines and early neurological worsening in ischemic stroke. Stroke 31: 2325–2329.
   PubMed Web of Science ®Google Scholar
• Vincent A, Palace J, Hilton-Jones D (2001). Myasthenia gravis. Lancet 357: 2122–2128.
   Google Scholar
• Vreugdenhil GR, Wijnands PG, Netea MG, van der Meer JW, Melchers WJ, Galama JM (2000). Enterovirus-induced production of pro-inflammatory and T-helper cytokines by human leukocytes. Cytokines 12: 1793–1796.
   Google Scholar
• Walker DG, Kim SU, McGeer PL (1995). Complement and cytokine gene expression in cultured microglial derived from postmortem human brains. J Neurosci Res 40: 478–493.
   PubMed Web of Science ®Google Scholar
• Wekerle H, Linington C, Lassmann H, Meyermann R (1986). Cellular immune reactivity within the CNS. Trends Neu-rosci 9: 271–277.
   Web of Science ®Google Scholar
• Whetsell WO Jr (1996). Current concepts of excitotoxicity. J Neuropathol Exp Neurol 55: 1–13.
   Google Scholar
• Wiegers GJ, Reul JM (1998). Induction of cytokine receptors by glucocorticoids: functional and pathological signifi-cance. Trends Pharmacol Sci 19: 317–321.
   PubMed Web of Science ®Google Scholar
• Wilckens T, De Rijk R (1997). Glucocorticoids and im-mune function: unknown dimensions and new frontiers. Immunol Today 18: 418–424.
   PubMedGoogle Scholar
• Yamabe T, Dhir G, Cowen EP, Wolf AL, Bergey GK, Krumholz A, Barry E, Hoffman PM, Dhib-Jalbut S (1994). Cytokine-gene expression in measles-infected adult hu-man glial cells. J Neuroimmunol 49: 171–179.
   Google Scholar
• Yamamura M, Yamada Y, Momita S, Kamihira S, Tomonaga M (1998). Circulating interleukin-6 levels are elevated in adult T-cell leukaemia/lymphoma patients and cor-relate with adverse clinical features and survival. Br J Haemato1100: 129–134.
   Google Scholar
• Yoles E, Hauben E, Palgi O, Agranov E, Gothilf A, Cohen A, Kuchroo V, Cohen IR, Weiner H, Schwartz M (2001). Protective autoimmunity is a physiological response to CNS trauma. J Neurosci 21: 3740–3748.
   Google Scholar
• Zidovetzki R, Wang JL, Chen P, Jeyaseelan R, Hofman F (1998). Human immunodeficiency virus Tat protein in-duces interleukin 6 mRNA expression in human brain endothelial cells via protein kinase C and Camp depen-dent protein kinase pathways. AIDS Res Hum Retrovir 14: 825–833.
   PubMed Web of Science ®Google Scholar
• Zuckerman SH, Shellhaas J, Butler LD (1989). Differential regulation of lipopolysaccharide-induced interleukin 1 and tumor necrosis factor synthesis: effects of endoge-nous and exogenous glucocorticoids and the role of the pituitary-adrenal axis. Eur J Immunol 19: 301–305.
   Google Scholar